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Abstract: Biomimetic membranes are attracting increased attention due to the huge potential of using
biological functional components and processes as an inspirational basis for technology development.
Indeed, this has led to several new membrane designs and applications. However, there are still a
number of issues which need attention. Here, I will discuss three examples of biomimetic membrane
developments within the areas of water treatment, energy conversion, and biomedicine with a focus
on challenges and applicability. While the water treatment area has witnessed some progress in
developing biomimetic membranes of which some are now commercially available, other areas
are still far from being translated into technology. For energy conversion, there has been much
focus on using bacteriorhodopsin proteins, but energy densities have so far not reached sufficient
levels to be competitive with state-of-the-art photovoltaic cells. For biomedical (e.g., drug delivery)
applications the research focus has been on the mechanism of action, and much less on the delivery
‘per se’. Thus, in order for these areas to move forward, we need to address some hard questions:
is bacteriorhodopsin really the optimal light harvester to be used in energy conversion? And how do
we ensure that biomedical nano-carriers covered with biomimetic membrane material ever reach their
target cells/tissue in sufficient quantities? In addition to these area-specific questions the general
issue of production cost and scalability must also be treated in order to ensure efficient translation of
biomimetic membrane concepts into reality.
Keywords: biomimetic; aquaporin; separation; sensing; biomedicine; energy-conversion
1. Introduction
The last decade has witnessed a rapid increase in new membrane materials and processes research
and development. If the last century witnessed productive synergy between physics/chemistry
and engineering, this century is likely to witness novel technology development driven by synergy
between biology and engineering [1]. Successful advances will be based on atomistic insights gained
from fundamental studies of molecular structure and function of biomolecules as well as process
developments based on integrated detailed knowledge about biological tissue and organ function.
A particularly promising area is research within membrane materials and membrane processes
where new technologies are inspired directly and indirectly from the natural membrane realm [2].
Biological membranes are capable of intricate transport of water, solutes, and gasses across thin
bimolecular films and can serve as an inspirational showcase for designing tailored permeability
properties in large-scale polymeric matrixes or for designing nano-scale compartments for complex
chemical reactions (e.g., catalysis and synthesis) [2,3]. Biological membranes are also able to perform
sensing and signal transduction/energy conversion—as exemplified by retinal photoreception and
photosynthesis—which may form the basis for design of biomimetic solar cells [4].
One manifestation in biomimetic membrane material developments is based on using bio-derived
additives—either in the form of natural or engineered/modified proteins, with desired sensing and
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separation properties. Another manifestation is based on de novo design of membrane functionalities
with design cues taken from one or more specific biological molecular structures such as ion-selective
channels [5]. In both approaches the additives must be stabilized by a suitable matrix or scaffold in
order to preserve the desired functionality [6].Also, process functionalities have biological correlates
which may serve as inspiration: for example in the nephron, ultrafiltration occurs at the barrier between
the blood and the filtrate in the glomerular capsule, and forward osmosis occurs in water reabsorption
from the tubular fluids [7].
Irrespective of the membrane designs investigated, a successful translation into technology
requires realistic estimations of capital and operational expenses (CAPEX & OPEX) associated with
the intended application. Very often this aspect comes into consideration only after the basic science
(including the selection of membrane materials and fabrication methods) behind a particular design has
been developed. From an innovation point of view the worst case outcome of this sequential approach
is that otherwise groundbreaking scientific results will never be translated into new technologies simply
because the selected materials and production methods are not scalable and/or not cost-effective
for the envisioned application. Thus, an approach where both scientific and economic aspects are
considered simultaneously from very early on in a discovery-driven process may constitute a more
viable path towards a commercial biomimetic product.
2. Biomimetic Membrane Technology Development Status
As of 2 July 2018, there is a total number of 3354 publications in Web of Science based on a
’biomimetic membranes’ text string search. More than 30% of these were published since 2015 with
authors from USA, China, Germany, France, UK, Italy and Korea accounting for more than 85% of
the publications illustrating the strong and growing global interest in the area. Many intriguing
phenomena has been described inspired by the remarkable functions of naturally occurring nano-scale
structures—in fields including membrane transport, catalysis, drug delivery, and electronics. Either,
as their physical and chemical properties are evident a priori; or as their structures and chemistry
are adjustable. However, for any nano-scale scientific result to be translated into a technology it
is imperative that fabrication methods and production costs are scalable and compatible with the
application intended and market segments addressed.
Here I will briefly discuss three examples where biomimetic membrane developments have
been pursued intensely over the last three decades: separation technology, energy conversion,
and biomedicine. All three biomimetic areas have made great progress, but they also exemplify
scientific, engineering, and commercialization challenges which must be overcome in order to translate
biomimetic membrane research into technology.
2.1. Membranes for Water Treatment Technology
A hallmark of biological membranes is their unique set of separation properties. This has led
to several biomimetic attempts to design and fabricate hydrophilic membranes for separation in
aqueous phases—most notably within the area of water purification. Here the use of aquaporin
protein channels has attracted particular attention. The main idea behind the use of aquaporin
proteins is their remarkably high water permeability (up to 109 H2O molecules s−1 for certain
isoforms including the mammalian AQP1 and the bacterial AqpZ [8]) reflecting the low energy
barrier for transport which amounts to around 5 kcal/mol—similar to the Gibbs activation energy for
water self-diffusion [9]. Thus, by incorporating aquaporin channels in a matrix impermeable to all
solutes one should in principle be able to achieve a high water flux with near ideal semi-permeability.
Several aquaporin membrane designs, see Figure 1, have been suggested within nanofiltration (NF)
membranes [10], reverse osmosis (RO) membranes [11], and forward osmosis (FO) membranes [12],
for reviews see [13,14].
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Figure 1. Two popular design concepts for biomimetic separation membranes [13]: (A top) a matrix 
of vesicles with reconstituted aquaporin proteins embedded in an immobilizing material (yellow) 
(e.g., polyamide) constitutes the selective layer formed on top of a substrate layer (blue) (e.g., 
polysulfone). (A bottom) a monolayer with the protein (red) directly embedded in a host membrane 
(orange) formed on top of a substrate layer (blue). (B) scanning electron micrograph of the design in 
(A). Scale bar 1 µm. The design in (A top) have also recently been used for creating membranes based 
on immobilized imidazole quartets [15]. 
The performance of any membrane design involving embedding aquaporin proteins (or any 
other water selective inclusion) in a host matrix will of course rely on the ability to incorporate 
sufficient amounts and to maintain functionality of the inclusion and the ability to create barrier 
properties of the matrix. Here a major issue in biomimetic membrane design based of the use of 
(integral) membrane proteins is the protein stability. Biological membrane protein stability is not 
given a priori as exemplified by the poor stability of G-protein coupled receptors in detergents [16]. 
Also certain proteins may require certain physical-chemical properties of the host membrane in order 
to function properly [17]. However, in the case of aquaporin proteins as the functional unit, proteins 
can be produced in high densities [18] and reconstituted in polymeric membranes with good 
functionality and stability [19].  
The functionality of biological membrane channels relies on intricate nanometer-scale physical 
and chemical interactions and this has also led to designs for making non-biological structures with 
high solute/water permeability and selectivity. One early example is the design of flat, ring-shaped 
cyclic peptides of alternating D- and L-α-amino acids. These peptides can self-assemble into stacks 
and form β-sheet-like tubular structures with the amino acid side chains on the outside surface of the 
nanotube [5,20]—akin to the fold-structure of linear gramicidin A channels [21]. The self-assembly is 
driven by H-bonding between the backbone amide groups in a reversible fashion with formation and 
disappearance of stacked structures. Regarding channels with specific water selectivity (i.e., with 
concomitant rejection of ions and other solutes), π-stacked dendritic dipeptides have been 
investigated [22] and transport of water and protons described qualitatively [23]. Barboiu et al. have 
investigated imidazole compounds where H-bonded ‘quartets’ with imidazole moieties are able to 
form water permeable channels in lipid bilayer vesicles [24]. These channels have transport rates of 
~106 s−1 with high rejection of cations, except for protons which may be transported in the opposite 
direction as water (probably occurring with co-transport of chloride anions induced by vesicle 
swelling and proton donation from the acid dye 8-hydroxypyrene-1,3,6-trisulfonate (HPTS) 
entrapped inside the vesicles). Concerted water and proton transport (with exclusion of ions) has also 
been qualitatively demonstrated in pyridine-based (6-aminopyridine-2-carboxylic acid) oligomers 
stabilizing in H-bonded helical stacks [25].  
Besides self-assembled systems also carbon nano tubes (CNTs) have been investigated as 
aquaporin protein channel mimics in terms of computer (Molecular Dynamics) simulations and 
experimental studies of water transport [26–28], for a comprehensive review see [29]. Potentially very 
high permeation rates (~108 s−1)—exceeding Hagen-Poiseuille flow—can be obtained. However, in 
order to achieve high water selectivity the CNTs inner diameter has to be ~3 Angstrom, increasing 
the diameter to ~5 Angstrom seemingly abolishes selectivity towards ions [26]. Fornasiero et al. 
Figure 1. Two popular design concepts for biomimetic separation membranes [13]: (A top) a
matrix of vesicles with reconstituted aquapori proteins embedded in an immob lizing material
(yellow) (e.g., polyamide) constitutes the selective layer formed on top of a substrate layer (blue)
(e.g., polysulfone). (A bottom) a monolayer with the protein (red) directly embedded in a host
membrane (orange) formed on top of a substrate layer (blue). (B) scanning electron micrograph of
the design in (A). Scale bar 1 µm. The design in (A top) have also recently been used for creating
membranes based on immobilized imidazole quartets [15].
The performance of any membrane design involving embedding aquaporin proteins (or any other
water selective inclusion) in a host matrix will of course rely on the ability to incorporate sufficie t
amounts and to maintain functionality of the inclusion and the ability to create barrier properties
of the matrix. Here a major issue in biomimetic membrane design based of the use of (integral)
membrane proteins is the protein stability. Biological membrane protein stability is not given a priori
as exemplified by the poor stability of G-protein coupled receptors in detergents [16]. Also certain
proteins m y require certain physical-ch mical properties f the host brane in o der to function
roperly [17]. However, in the case of aquaporin proteins as the f nctional unit, proteins can be
produced in high densities [18] and reconstituted in polymeric membranes with good functionality
and stability [19].
The functionality of biological membrane channels relies on intricate nanometer-scale physical
and chemical interactions and this has also led to designs for making non-biological structures
with high olute/water permeability and selectivity. One early example is the design of flat,
ring-shaped cyclic peptides of alternating D- and L-α-amino acids. These peptides can self-assemble
into stacks and form β-sheet-like tubular structures with the amino acid side chains on the outside
surface of the nanotube [5,20]—akin to the fold-structure of linear gramicidin A channels [21].
The self-assembly is driven by H-bonding between the backbone amide groups in a reversible
fashion with formation and disappearance of stacked structures. Regarding channels with specific
water selectivity (i.e., with concomitant rejection of i ns and other solutes), pi-stacked ndritic
dipeptides have been investigated [22] and transport of water and protons described qualitativ ly [23].
Barboiu et al. have investigated imidazole compounds where H-bonded ‘quartets’ with imidazole
moieties are able to form water permeable channels in lipid bilayer vesicles [24]. These channels have
transport rates of ~106 s−1 with high rejection of cations, except for protons which may be transported
in the opposite direction as water (probably occurring with co-transport of chloride anions induced by
vesicle swelling and proton donation from the acid dy 8-hydroxypyrene-1,3,6-trisulfon te (HPTS)
entrapped inside the vesicles). Concerted water a proton transport (with exclusion of ions) has also
been qualitatively demonstrated in pyridine-based (6-aminopyridine-2-carboxylic acid) oligomers
stabilizing in H-bonded helical stacks [25].
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Besides self-assembled systems also carbon nano tubes (CNTs) have been investigated as
aquaporin protein channel mimics in terms of computer (Molecular Dynamics) simulations and
experimental studies of water transport [26–28], for a comprehensive review see [29]. Potentially very
high permeation rates (~108 s−1)—exceeding Hagen-Poiseuille flow—can be obtained. However,
in order to achieve high water selectivity the CNTs inner diameter has to be ~3 Angstrom, increasing the
diameter to ~5 Angstrom seemingly abolishes selectivity towards ions [26]. Fornasiero et al.
demonstrated that negatively charged functionalities (carboxylic groups) at the tube entrance may
endow larger (sub-2-nm) CNTs with ion rejection capabilities as high as 98% for salt solutions with a
Donnan z−/z+ ratio of 3 [30]. However, for KCl (where z−/z+ = 1) solutions, the maximal rejection
they obtain is <55% and generally, rejection is <10% at solution concentrations >10 mM irrespective of
the z−/z+ ratio [30]. Recently, experimental results on narrow CNTs with very high water permeability
and selectivity (six fold higher than for the mammalian aquaporin 1 (AQP1) isoform, and no anion
transport) have been reported [31]. However, the interpretation of these results have been debated
illustrating the technical difficulties in quantifying single channels water permeability [32,33].
Common for both aquaporin proteins and artificially made water permeable structures is that high
water permeability and high solute rejection is established by having a narrow hydrophilic constriction
(down to ~3 Angstroms) allowing for formation of a one-dimensional water wire with H-bonding
between water molecules, and bonding/polarizing interactions between water molecules and channel
lumen wall, for recent reviews see [34,35]. These new types of membrane materials and components
could in principle lead to fundamental improvements of membrane performance and thus may open
up for new application areas both in existing and emerging market segments. However, it is not clear
what the technological benefits are of radical improvements in membrane water permeability and
water−solute selectivity. Do we need ultrahigh permeation or rejection? This question is of course not
answerable in general terms. For desalination, which can be seen as the representative high-demanding
membrane separation application, it has been argued that increased water-solute selectivity is more
important than water permeability where a reasonable target for an RO desalination membrane is
2–4 L m2 h−1 bar−1 with near-ideal (i.e., >99.8%) rejection of NaCl at any ionic strength combined
with high rejection of low molecular weight components (e.g., trace organics) [36]. For low pressure
(tap water) RO membranes a target would be 9–10 L m2 h−1 bar−1 with NaCl rejection > 95% [37].
Thus, for any biomimetic water treatment membrane design to be translated into a technology
there are a number of issues beyond basic performance parameters (water flux and solute rejection)
which needs to be addressed. Among these is the ability to scale up production of membrane
components. Another issue is the potential health hazards related to the bio/nano compounds
eventually used in biomimetic membrane fabrication. Many membrane applications involve contact
with food and beverage ingredients. For food contact materials, migration limits have been set
for many substances based on toxicological risk assessment and these limits are now an integral
part of food contact regulations. Hence migration tests should in principle capture any (unwanted)
transfer of potentially hazardous compounds from food contact materials (e.g., membranes) into food.
Tests typically include an overall migration limit (OML) which applies to the sum of all substances
that can migrate from the food contact material to the food (or food simulant) [38]. The OML can thus
be seen as a measure for the inertness of the material—and for membranes a high degree of inertness
is generally desirable. In addition, Specific Migration Limits (SMLs) may have to be quantified for
individual substance based on toxicological studies [38].
Small pore-forming molecules are known to possess antibiotic activity (e.g., gramicidin A) and it
is presently not clear if any of the artificially made channel-forming molecules may also have antibiotic
activity—where leakage of these compounds from the membrane is not acceptable. A similar issue
may arise from the use of potentially hazardous compounds (e.g., imidazole-based pore forming
compounds [24]) in substantial amounts. Finally, small nm-sized CNTs, potentially leaking from
the membrane, may also present a potential health hazard being small and highly stable xenobiotic
molecules [39].
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In terms of commercialization, none of the designs involving non-biological water permeable
entities have yet made any impact reflecting the abovementioned challenges in up-scaling and using
these designs. Regarding aquaporin-based membranes, the Danish water technology company
Aquaporin A/S is now producing and commercializing aquaporin membranes for RO and FO. The RO
membrane modules are based on thin film composite (TFC) membranes in a classic spiral wound design
(from small 1812 sized modules for low pressure RO applications to industrial size 4040 and 8040
modules) and the FO membrane modules are based on a hollow fiber design (with effective membrane
areas up to 2.3 m2 per module). These membrane and modules have been tested for a number of
applications. Specifically, FO membranes have been tested with respect to cleaning procedures [12,40],
exposure to municipal secondary wastewater effluent [40], allowing for improved capture of carbon
an phosphorous [41]. The FO aquaporin membrane concept has also been demonstrated in water
recovery from molasses distillery wastewater where recovery could reach 70% compared to 35–45%
for standard RO membrane treatment. Also, FO aquaporin membranes have been evaluated in a
submerged osmotic bioreactor pilot experiment demonstrating the advantage of a low reverse salt
flux resulting to a less severe salinity build-up in the reactor [42]. The significance of low reverse salt
flux is particularly important in applications in which the concentrated FO feed solution is the desired
product—such as in up-concentration of beverages/fragrances (e.g., fruit juice and coffee). This was
recently demonstrated in the case of coconut milk up-concentration [43].
The aquaporin membrane (FO and RO) used in the applications described above is based on
a design where aquaporin laden polymersomes (e.g., based on poly (2-methyl-2-oxazoline)-b-poly
(dimethylsiloxane)-b-poly(2-methyl-2-oxazoline) (PMOXA-PDMS-PMOXA)) are integrated into a
polyamide matrix. This design obviously raises the question if any of the constituent elements are
prohibitively expensive to manufacture and/or present environmental or health risks. In terms
of cost all elements in the aquaporin TFC design—except the proteins—are available in bulk
commodities as they already are extensively used in classical dense membrane (e.g., RO) production.
The aquaporin protein is not yet a bulk commercial product, but yields as high as 45 g/100 L
fermentation has been shown with excellent purifications obtained using cost-effective detergents [43].
In terms of environmental concerns, the classical TFC membrane design is an accepted technology
as exemplified by state-of-the art RO membranes. PMOXA-PDMS-PMOXA polymersomes are
regarded as biocompatible [44] and aquaporin proteins are ubiquitous in edible plants such as in
spinach leaves where it constitutes 20% of the total integral plasma membrane protein amount [45].
Thus, there are no apparent cost- or safety-issues related issues preventing industrial applications as
such. However, there may still be commercialization challenges where the issues of stability, resistance
to cleaning agents etc. are important. With respect to stability FO membrane performance has been
tested and found stable over a period of at least one year [12] and this type of membrane also showed
stability towards standard cleaning procedures [39].
Not only biological membranes have served as inspiration for designing separation membranes.
Also, hydrophobic surfaces may be used in designing new membrane properties. In particular,
super-hydrophobic surfaces, with a water contact angle >150◦ have been studied as exemplified by
the lotus leaf where the hydrophobic effect arises from the surface being covered with columnar
structures—papillae—about 10–20 µm in height and 10–15 µm in width coated with so-called
epicuticular waxes. Based on this, several biomimetic thin membrane designs with strong hydrophobic
properties have been proposed and attracted interest because of their high separation efficiency in
oil/water mixtures [46]. Although such materials show potential based on laboratory scale experiments
there are still major challenges to overcome. A key issue is that the extreme hydrophobicity requires
that the nano-scale structures giving rise to the hydrophobicity are robust and not easily damaged
by chemical and mechanical stress. Membrane fouling and physical damage will seriously impede
applications. Also, it still remains to be seen how the synthesis methods can be carried out in large-scale
industrial production. Methods based on controlled growth or advanced lithography may require
reagent purities and production facilities which are not easily compatible with low-cost production of
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(expendable) membranes to be used in large-scale applications such as industrial oil/water separation.
Beyond these issues there is also a more general membrane technology issue in securing effective
separation of feed oil/water emulsions based on a super-hydrophobic porous material as the emulsion
droplet size may span a large range: from nanometers to micrometers—and that emulsions may be
highly viscous/thixotropic.
2.2. Membranes for Energy Conversion
In terms of large scale energy conversion conventional membranes currently play a role within
the area of hydrogen separation where inorganic membranes for hydrogen separation are being
investigated and used commercially. These include palladium membranes, mixed proton/electron
conductive materials, and molecular sieve membranes based on silica or zeolites [47]. All these
membranes are operated in the range of 300–600 ◦C—and in some cases at even higher temperatures
at which no biological processes occur and therefore we do not have any direct biomimetic correlates.
In some applications polymer membranes can be used at lower temperatures (20–80 ◦C) where an
H2/CH4 selectivity of about 100 [48] which is of particular relevance in biogas production.
Generally, direct biomimetic inspiration based on gas permeation in cells and tissues may hold
future potentials in terms of technology developments within the area of gas separation related to
CH4 production and CO2 capture—but so far developments have focused on indirect biomimetics.
These developments include fabrication of mixed matrix membranes inspired by biomineralization
exemplified by silica deposition in diatoms and sponges used in fabrication of CO2/CH4(N2) separation
membranes [49], and by metal-organic frameworks where for example poly (N-vinylimidazole)–zinc
complexes has been prepared to simulate the zinc active site of carbonic anhydrase which was
subsequently immobilized in membranes for CO2/N2 separation [50]. Ye et al. have used biomimetic
aquaporin FO membranes to crystallize CO2 by controlling the supersaturation rate for production of
Na2CO3·10H2O. They achieved a 99.94%. purity with a water flux one to two orders of magnitude
higher than other membrane approaches used for capture (e.g., membrane contactors and RO
membrane crystallizers) [51]. However, until now none of these biomimetic approaches have found
any commercial application.
In terms of energy production semipermeable membrane may also find application in pressure
retarded osmosis (PRO). PRO can be used to generate power from a transmembrane salinity gradient
established by two different aqueous salinity streams. Originally PRO was envisaged to be applicable
for sea/freshwater [52] but low energy output in this scenario has so far hampered PRO technology
development which has led to consider gradients arising from hypersaline and fresh waters [53].
It is now generally accepted that in order for PRO to be economically feasible the energy density,
i.e., the energy produced per unit membrane area, has to be at least 5 W/m2 [53]. A perquisite
for reaching this density is a sufficient water flux and here aquaporin-based membranes may be
advantageous given the potential for having a high water flux. FO aquaporin membranes have
been tested in a model PRO study but with limited success (low water flux at salinities <2 M) [54].
Thus, more work is needed in order to clarify the potential of aquaporin membranes in PRO. Here a
major issue will be to ensure low internal concentration polarization in the membrane material [55].
This can in principle be achieved by using very thin and porous membranes, but for optimal PRO
energy production the membranes must be pressurized—which puts considerable demands on
membrane material properties in terms of tensile strength.
Energy conversion related to photovoltaic applications have been an area of interest in biomimetics
since the first reports describing photosensitization of ZnO semiconductors using chlorophyls [56].
Strictly speaking these systems are not membrane-based but they exemplify the general idea of using
a biological molecule to provide effective electron injection into a semiconductor material. This can
also be achieved with the membrane protein bacteriorhodopsin (bR) where transient photocurrents
generated by bR [57,58] and other light-driven pumps upon illumination have been demonstrated
in systems where a surface layer (e.g., Au, SnO2, TiO2 or Indium tin oxide (ITO)) has been coated
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with membrane proteins (often in the form of purified protein from Halobacterium salinarium purple
membrane) in the presence of a redox electrolyte [59,60], see Figure 2A,B.
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Figure 2. (A) Principal diagram of BSSC based on bR/purple membranes immobilized on TiO2 spheres
(red) which are deposited on a fluorine-doped tin oxide (FTO) conducting glass. This acts as the working
electrode with an FTO surface covered with aluminium (Al) or platinum (Pt) as counter electrode.
A redox electrolyte (e.g., based on I−/I2−) is encapsulated between the FTO slides. The photon induced
photocurrents arises from excitation of bR leading to electrons being injected into the FTO working
electrode. The maximal output (VOC) is determined by the difference between the Fermi level and
redox level. (B) Photo-current/photo-voltage (I/V) relation. VOC: open circuit voltage; ISC: short circuit
current (at VOC = 0). VMP: voltage at maximal power output PMAX. IMP current at PMAX. The ratio
between the yellow area and orange area defines the fill factor (FF), see also Table 1.
Due to the relative ease of production and high stability of bR [61,62], both wild type and
engineered bR have been investigated for optoelectronic [63] and power production (solar cell)
applications [4,59]. However, no commercially available bR-based biomimetic technology exists
today. In order to assess the potential of bR-based technologies one must address potential unique
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selling points for a bR-based technology. Provided production costs and robustness issues are
solved, bR may eventually find applications within optoelectronics (e.g., in holographic storage
or switching/gating devices) due to its fast differential responsivity with light-induced responses
occurring within picoseconds [64]. Here the value proposition for the technology will arise from
comparison with current state-of-the-art response time of semiconductor photodiodes which is in the
range of 3–300 ns [65]—thus, three orders of magnitude slower.
In terms of power production, the use of bR has been suggested as a promising concept in
producing energy in bio-sensitized solar cells (BSSCs). However, the power densities obtained so far
with bR have not been comparable with what has been demonstrated using chlorophyll, or organic dyes
as sensitizers in conventional photovoltaic cells in which a colloidal suspension of TiO2 nanoparticles
have been spread on conductive glass, see Figure 2A and examples in Table 1. A major challenge is to
ensure a sufficient density or coating of bR onto the anodic semiconductor material. Also, the general
design implies that the cathode (from which the electrons are released to interact with the redox
mediator) is on top of the anode with the sandwiched electrolyte volume separating the two. This will
also tend to decrease the overall efficiency.
In some experiments bR has been compared with bacterioruberin (bRu), a linear C50-carotenoid
naturally residing in biological membranes, which has photosensitizing properties—although not
to the same degree as bR, see Table 1. Interestingly when both bR and bRu are present there is a
cooperative effect enhancing both Jsc, Voc, and η. This suggests a direct photosensitizing role of bRu
having a close interaction with bR, apart from the biological role of bRu as antioxidant and regulator
of membrane structural/ physical-chemical properties [66]. In other recent developments bR has been
coupled to quantum dots where the quantum dots serve to absorb the energy and then transfer it to the
bR via Förster energy resonance transfer in order to enhance the spectral range for the BSSC [67,68].
Table 1. 1 Performance data for selected BSSCs.
BSSC Substrate
Cell Area Short CircuitCurrent
Open Circuit
Voltage
Illumination
Intensity j Efficiency Fill Factor Ref
A [cm2] ISC [A/m2] VOC [V] P [W/m2] H [%] FF -
bR-TiO2 g 0.5 0.9 0.35 400 0.002 a 0.24 b [59]
bR-TiO2 h <2 2.3 0.22 600 0.03 c 0.67 d [69]
bR-TiO2 e 0.25 10 0.53 1000 0.35 0.66 [70]
bR-TiO2 e 0.25 2.8 0.52 1000 0.09 0.62 [71]
bR-TiO2 f 0.25 2.1 0.53 1000 n.a. n.a. [71]
bR-TiO2 e 0.25 4 0.5 1000 0.11 n.a. [72]
bRu-TiO2 e 0.25 2.1 0.53 1000 0.11 n.a. [72]
(bRu + bR)-TiO2 e 0.25 4.5 0.57 1000 0.16 0.62 [72]
Cu-2-α-oxymesoisochlorin e4-TiO2 i 1.0 90 0.52 1000 2.6 0.7 b [73]
N719 (Di-tetrabutylammonium
cis-bis(isothiocyanato)bis(2,2′-bipyridyl-
4,4′-dicarboxylato)ruthenium(II))-TiO2 e
0.25 90.5 0.77 1000 5.9 - [71]
a: calculated from Figure 11 in [59] using a linear approximation of the VOC-ISC relationship. b: FF =
(VOC·ISC)Pmax/VOC(max)·ISC(max). [74]. c: η = VOC(max)·ISC(max)·FF/Pincoming [74]. d: approximated by eye from
Figure 11 in [69]. e: with Pt-coated FTO glass as counter electrode. f: with C-coated FTO glass as counter electrode.
g: with Al-coated FTO glass as counter electrode. h: nanotube arrays. i: Pt as counter electrode. j: white light
illumination. 1: Table 1 is by no means exhaustive, but serves to provide exemplary values for ISC, VOC, FF, and η in
biomimetic systems allowing for direct comparison with conventional photovoltaic cells.
In all bR experiments above the basic mechanism (electron injection into the semiconductor)
relies on changes in the protonation state of acidic and basic groups in the proteins and thus bR
proton coupled electron transfer upon photoexcitation. This is therefore different as compared to the
biological situation where bR function is directly related to its proton pumping capability thereby
creating a transmembrane pH gradient which in turn can drive energy production in terms of ATP.
Future developments using bR for energy conversion may be able to use proton gradients directly—but
this will require development of biomimetic host membranes capable of maintaining these gradients
once generated [75]. In any case, the fundamental—and still open—question related to bR in energy
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conversion remains: can we ever reach a sufficient energy density using this protein compared to
dye-sensitized solar cells? A quantitative answer to this question not only relies on quantum yields of
the protein but also on detailed knowledge about the specific architecture envisioned for a bR-based
energy conversion: i.e., is the architecture optimal for light harvesting in terms of light access to bR
and surface density of the protein. If these quantitative predictions are not successfully translated into
design criteria we may never move beyond the current conceptual proof-of-principle state.
2.3. Biomimetic Membranes and Membrane Processes for Biomedical Applications
Also, biological processes and cellular structures serve as biomimetic inspiration for membrane
based processes. Here developments have been dominated by two complementary concepts:
protocell/cell-like systems and biomimetic organelles. Both concepts may lead to and increased
understanding of physiological processes, but also eventually lead to applications within medical
therapy and diagnostics.
The area of protocell/cell-like systems for medical treatment has developed widely since the
seminal discovery in 1986 that passive accumulation of nano-sized particles occurs within tumors [76].
This has spurred developments within oncology where protocell/cell-like structures with membrane
mimicking surfaces has been as drug carriers based on the enhanced permeation and retention effect
in solid tumors where blood vessel walls have pores with diameters up to a few hundred allowing
for passage of similar sized carriers into the tumor proper [77,78]. Later the permeation concept
has been modified to also include transcellular transport pathways [79]. Numerous nano-carriers
or nanoparticles—many with membrane mimicking or membrane protein decorated surfaces—have
been designed with the aim to conquer and destroy cancer cells and the efforts summarized in several
reviews [80–82], see examples in Figure 3. Despite massive research efforts over three decades we still
do not have a single clinical therapy realized based on nano-carriers with biomimetic properties.
This situation has recently been described in sobering detail by Wilhelm et al. who analyzed
cancer therapy nanoparticle delivery efficiency based on an extensive literature survey based on 232
independent datasets [83]. They found that only 0.7% (median) of an injected dose ever reached the
tumor. Furthermore, that the choice of nanoparticle material (organic/inorganic), targeting strategy
(passive/active), hydrodynamic diameter, zeta potential, shape, tumor model or cancer organ target
only had modest influence on this value (i.e., the median efficiency ranged between 0.5 and 1.1%).
One of the main reasons for this low efficiency is that the mononuclear phagocytotic system and the
renal system will naturally tend to scavenge (and destroy) 99% of the administrated nanoparticles.
This calls for even more work on cell-cell (i.e., membrane-membrane) recognition mechanisms in order
to both mitigate this and to improve tumor targeting. If this fails, there is a risk that ‘biomimetic
nanomedicine’ will end as a hyped research area but also a seriously underperforming technology area.
The biomimetic organelle (multi-compartment) research has also attracted increasing attention
over the last decades. Here, several strategies for obtaining these structures have been pursued
including combined self-assembly and layer-by-layer assembly of amphiphilic polymers with the
use of suitable (degradable) scaffolds (e.g., calcium carbonate), surface-initiated polymerization,
and interfacial (emulsion) polymerization schemes resulting in formation of aqueous (liquid or gel
based) droplets stabilized by surrounding polymer layers. Thus, one may create lipid-based systems
(vesosomes) or mixed lipid-polymer systems (capsosomes) where a polymersome is encapsulating
liposomes, for reviews see [84–86]. A recent example of a biomimetic compartmentalization design
is a study in which artificial organelles with endogenous stimuli-triggered enzymatic activity were
developed [87]. Specifically, polymersomes were used to host genetically modified outer membrane
protein F porins. These proteins induce redox responsiveness with encapsulated horseradish
peroxidase and activated by intracellular glutathione levels in vitro and importantly also in vivo in
a zebrafish embryo model. This work is an important step towards human personalized protein
therapy, but evidently more work is needed in terms of translating this proof-of-concept into
medicine. Besides direct membrane biomimetics more general designs have been proposed such as a
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multi-membrane liquid-membrane hybrid inspired by the general structure and composition of the
bacterial cell envelope. Such systems may be used in Donnan dialysis and pertraction/pervaporation
systems although no technology based on these ideas have been developed yet [88].
  
Membranes 2018, 8, x; doi: FOR PEER REVIEW  www.mdpi.com/journal/membranes 
 
 
 
(A) 
 
(B) 
 
(C) 
Figure 3. Examples of thermo-responsive nano-carrier designs with biomimetic membrane coatings 
where the basic mechanism of action is to induce a local temperature increase by near-infrared laser 
illumination to >43 °C which leads to hyperthermal tissue (tumor) destruction. (A) Red blood cell 
mimicking carrier for delivering paclitaxel (PTX) using 808 nm laser irradiation which is captured by 
the membrane embedded DiR dye molecule. The ensuing thermal energy triggers a DPPC phase 
transition and core destruction, resulting in the release of the chemotherapy medication PTX [89]. (B) 
Cancer cell mimicking carriers for delivering the diagnostic dye indocyanine dye. By utilizing binding 
molecules from cancer cell membranes adhesion to homologous cancer cells can be achieved while 
the DPPE-PEG prevents phagocytosis non-specific binding to serum proteins resulting in tumor 
accumulation of the nano-carrier. Irradiation at 780 nm results in energy absorption in ICG and 
thermal destruction of the tumor [90]. (C) Macrophage-camouflaged carrier where macrophage 
proteins provide molecular recognition with tumor proteins and the Au-coated silica core allows for 
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Figure 3. Examples of thermo-responsive nano-carrier designs with biomimetic membrane coatings
where the basic mechanism of action is to induce a local temperature increase by near-infrared laser
illumination to >43 ◦C which leads to hyperthermal tissue (tumor) destruction. (A) Red blood cell
mimicking carrier for delivering paclitaxel (PTX) using 808 nm laser irradiation which is captured by the
membrane embedded DiR dye molecule. The ensuing thermal energy triggers a DPPC phase transition
and core destruction, resulting in the release of the chemotherapy medication PTX [89]. (B) Cancer cell
mimicking carriers for delivering the diagnostic dye indocyanine dye. By utilizing binding molecules
from cancer cell membranes adhesion to homologous cancer cells can be achieved while the DPPE-PEG
prevents phagocytosis non-specific binding to serum proteins resulting in tumor accumulation of the
nano-carrier. Irradiation at 780 nm results in energy absorption in ICG and thermal destruction of
the tumor [90]. (C) Macrophage-camouflaged carrier where macrophage proteins provide molecular
recognition with tumor proteins and the Au-coated silica core allows for energy absorption at 808 nm
leading to thermal tumor destruction [91].
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In conclusion, even though the biomedical application area involving biomimetic membranes
is indeed promising, we still need to define addressable sub-problems for which we can eventually
document progress both in terms of medical/physiological effects and feasible physical–chemical
mechanisms. Here, the problems of delivery and robustness must be treated in parallel with designing
the mechanism of action.
3. Outlook
In terms of technological readiness of the three areas discussed here, it appears that biomimetic
separation membranes are the most developed with commercial products (membranes and modules)
on the market for water treatment technologies. The water market is strongly segmented which makes
it a good area for identifying niches with a strong market-pull in which to introduce new technologies
and obtain proof-of-market. Of particular interest are ‘high-value’ niches where the customer is willing
to pay a premium price for products yet not produced in massive volumes—and in general this may be
a thing to consider for commercialization of any biomimetic technology where the very first products
are yet to benefit from an optimized production capability.
However, appealing market niches may also hold challenges beyond those related to product
itself. For example FO, which can be considered an emerging water technology, a successful market
entry not only depends on value propositions related to the membrane performance but also on
market acceptance of the FO concept itself. For other membrane application segments such as RO,
successful market entry primarily depends on value propositions rooted in increased water flux/solute
rejection (compared to conventional RO membranes) coupled with documented long-term stability
and robustness to cleaning protocols. A special challenge is related to use of separation membranes for
food and beverage applications where material safety issues must be fully addressed before relevant
certifications can be obtained.
Despite many efforts biomimetic membranes for energy conversion are still to be considered at
the R&D stage. Until now, membrane protein (bR) based approaches have not been able to compete
in performance with other BSSC designs in terms of photovoltaic energy efficiency. This may reflect
the need for increased protein loading per unit solar cell area, but it also reflects the relatively limited
spectral range for bR activation which may be augmented by including additional activation-enhancing
components. These issues must be addressed and paired with realistic OPEX/CAPEX estimations
before large-scale proof-of-concept studies can be realized.
Biomimetic membranes for biomedical applications may have a huge potential, but perhaps
also have the largest market entry barriers. A major barrier is the extensive in vivo validation
studies needed before any of these methods will be able in the clinic. Here the focus and
associated success criteria should not only be related to proof-of-concepts for specific mechanisms
based on vesosomes/capsosomes or particles with membrane-mimicking coats targeting specific
disease pathways and/or manifestations (e.g., tumor cells) but also on how to quantify and control
accumulation/aggregation, phagocytic sequestration, and elimination via renal clearance of biomimetic
membrane-based particles (and devices) in the body. Also cross-species analysis of animal models will
be indispensable in translating model studies into medical applications within human care diagnostics
and treatments.
A general feature of many biomimetic mechanisms is that they may work very well at the
nano-scale at which the process of interest often occur (i.e., molecular selectivity and recognition),
but many large scale applications will require large sufficiently purified amounts of the functional
component (e.g., membrane proteins) and/or auxiliary materials which may not be readily available.
Elaborate fabrication methods may also be a hindrance for a cost-effective up-scaling of the technology.
Finally, regulatory safety aspects as well as life cycle assessment must also be considered when
introducing and using ‘new’ biomimetic components and processes in membrane fabrication.
This is obvious for medical applications but will in fact apply to all technical applications of
biomimetic technology.
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